You searched for "OCT"

2128 results found

Microvasculature changes of mCNV after ranibizumab treatment using OCTA

In this study the authors aim to evaluate the vascular changes of myopic choroidal neovascularisation (mCNV) after ranibizumab treatment using optical coherence tomography-angiography (OCTA). The 3×3 OCTA en face images were analysed for the absence / presence of mCNV, CNV...

OCTA in diabetic macular oedema treated with intravitreal aflibercept (DOCTA Study)

Central vision loss due to diabetic macular oedema (DME) can be attributed not only to presence of the macular oedema itself but also, in some cases, to alterations of the foveal avascular zone (FAZ). The DOCTA trial was a longitudinal,...

The National Treatment Centre-Highland

The National Treatment Centre-Highland opened its doors to patients in April 2023. At a cost of £48 million this represented a significant investment by the Scottish Government for the provision of modern eye care for the North of Scotland.

Ophthalmology Specialty Training 2024: What's different?

The 2024 intake for ophthalmology specialty training (OST) has undergone several significant changes in its approach towards candidate selection and assessment. This article provides a comparative analysis, detailing these new measures and comparing them against the previous year's standards. Our...

Anterior segment imaging: a photographer’s view

My name is Rosalyn Painter and I work within the vision science and ophthalmic imaging team at Bristol Eye Hospital, where we cover all aspects of imaging within the hospital, including fluorescein angiograms, fundus photography, optical coherence tomography (OCT), slit-lamp...

How the other half live – ophthalmology training around the world

Ophthalmology speciality training is currently seven years in the UK without an additional fellowship. UK trainees are privileged to have a training programme that is held in high esteem across the world, but did you ever wonder what other trainees...

What not to miss in neuro-ophthalmology Part 2

As mentioned previously there are several conditions in neuro-ophthalmology that should not be missed by the general ophthalmologist as well as ophthalmology trainees. We discussed in the first part some of these conditions including third cranial nerve palsies, giant cell...

RCOphth 2024 Report

A comprehensive tapestry of all our RCOphth Annual Congress content captured between 20–23 May 2024.

Outcomes of treat & extend ranibizumab in diabetic macular oedema

This study retrospectively evaluated 118 eyes of 87 patients who received ranibizumab in a treat and extend regimen for diabetic macular oedema (DMO). Data were collected for patients under follow-up for 24 months. After 24 months, patients gained a mean...

Technique of deep corneal foreign body removal

This article has been verified for CPD. Click the button below to answer a few short questions and download a form to be included in your CPD folder. The objective is to demonstrate a method for the safe and successful...

The Worshipful Company of Spectacle Makers rewards early career research

The Worshipful Company of Spectacle Makers (WCSM) this week announced the winners of its annual bronze medal award competitions for vision research. Both the winning submissions demonstrated models for earlier diagnosis of significant eye disease and have the capacity to...

Intravitreal afibercept and ranibizumab for PCV

This is a retrospective, interventional series comprising 98 eyes with polypidal choroidal vasculopathy (PCV) with the aim of comparing treatments with afibercept and ranibizumab, highlighting any differences in their efficacy. Case notes and imaging (FFA / ICG / OCT) were...